, Tracking Stock Market Picks
Enter Symbol:
Somaxon Pharmaceuticals, Inc. (SOMX) [hlAlert]

down 90.64 %

Somaxon Pharmaceuticals, Inc. (SOMX) rated Outperform with price target $10 by RBC Capital Mkts

Posted on: Tuesday,  Feb 12, 2008  8:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) on 02/12/2008, when the stock price was $32.08.
Since then, Somaxon Pharmaceuticals, Inc. has lost 90.65% as of 03/06/2015's recent price of $3.00.
If you would have followed this RBC Capital Mkts's recommendation on SOMX, you would have lost 90.64% of your investment in 2579 days.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. Somaxon's lead product candidate, SILENOR, is in Phase III clinical trials for the treatment of insomnia

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2008 8:25 AM Buy
32.08 80.00
as of 12/24/2008
1 Week down  -7.50 %
1 Month up  2.77 %
3 Months down  -83.91 %
1 YTD down  -73.18 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy